# Independent scientific interpretation of the final batch

Reviewer: `/root/source_proposal_review_b`. Date: 5 November 2026. This interpretation uses the completed batch's `evaluation/RESULTS.json`, the six initial candidates' decisions and model specifications, and their source-proposal reviews. References were available to this reviewer only after the controller declared all six constructors terminally closed. No participant rows, new clinical fits, changed parameters or additional experiments were used. The reference comparisons are exposed development evidence, not a new blinded validation.

The batch supports **usable, inspectable scenario cohorts with partial analytical fidelity**. It does not establish that the virtual tables can replace measured cohorts for quantitative target-population inference. The important result is the coexistence of consistent point directions with substantial discrepancies in effect sizes, residual dependence and dispersion. These are properties of the final virtual data, not merely shortcomings in documentation.

Six fresh constructions addressed two requests and delivered 18 distinct successful tables, three seeds per construction. Each table contains 3,000 synthetic records. The 18 tables are repeated simulations under six fixed laws, not 18 clinical replicates; the constructions share sources, a model service and a review workflow. The 24 physical attempts comprise the six initial trials and 18 final deliveries. All six constructors retained their initial numerical models. Repeated seeds describe sampling variation within those choices and do not quantify uncertainty about their source evidence, structures or transport.

## Native-unit analytical behavior

The table entries below are means across each construction's three scheduled final tables. They are descriptive summaries, not pooled clinical estimates. Q1 is the requested adjusted age coefficient; Q2 and Q3 are the requested BMI coefficients before and after the additional glucose adjustment.

| HbA1c quantity | Exposed sample reference | H01 | H02 | H03 |
|---|---:|---:|---:|---:|
| Q1 age effect, HbA1c percentage points per 10 years | 0.0751 | 0.0995 | 0.0995 | 0.1009 |
| Q2 BMI effect, HbA1c percentage points per 5 kg/m² | 0.0836 | 0.0603 | 0.0489 | 0.0566 |
| Q3 BMI effect, HbA1c percentage points per 5 kg/m² | 0.0566 | 0.0305 | 0.0194 | 0.0510 |

All three HbA1c constructions give a larger age effect and smaller Q2 BMI effect than the reference point. H03 is closer on Q3, whereas H01 and H02 retain markedly smaller glucose-adjusted BMI effects. This supports endpoint-specific descriptive comparison, not a general ranking. A source-supported adjusted coefficient can still differ after transfer to the requested setting; a well-documented cross-source construction is not automatically accurate in the target.

| Lipid quantity | Exposed sample reference | L01 | L02 | L03 |
|---|---:|---:|---:|---:|
| HDL BMI effect, mg/dL per 5 kg/m² | −4.623 | −2.187 | −2.100 | −1.987 |
| TC BMI effect, mg/dL per 5 kg/m² | 5.683 | 10.394 | 11.261 | 10.015 |
| Pearson correlation of the two adjusted lipid residuals | 0.5121 | 0.1112 | 0.1083 | 0.1413 |

The lipid laws reproduce the reference point directions but attenuate the HDL association, produce larger TC association points, and substantially underrepresent the residual TC–HDL dependence. The latter is central to joint virtual-data utility: apparently plausible separate margins or regression signs do not preserve the relationship remaining after the same age/sex/BMI adjustment. None of these lipid constructions recovers that reference joint feature.

All 54 primary endpoint-by-table point-direction comparisons agree with their reference points. This is a narrow descriptive success. The TC reference's HC3 normal sensitivity band is approximately −3.754 to 15.120 mg/dL per 5 kg/m² and crosses zero; positive synthetic TC coefficients therefore do not demonstrate recovery of a securely established positive target direction. The lipid slope bands are assumption-conditional sensitivities, not design-based confidence intervals. The HbA1c reference bands are empirical cluster-resampling stability bands, not national confidence intervals. Neither family supplies an equivalence margin or an acceptance threshold, and there is no residual-correlation reference interval. Being inside a broad band does not establish acceptable virtual-data fidelity.

## Dispersion changes the utility assessment

The following are also three-table means. HbA1c uses the reported population-SD diagnostic; lipids use the reported sample-SD diagnostic. These are not interchangeable with residual RMS or coefficient uncertainty.

| Dispersion quantity | Exposed sample reference | Construction 1 | Construction 2 | Construction 3 |
|---|---:|---:|---:|---:|
| HbA1c marginal SD, percentage points (H01/H02/H03) | 0.5274 | 0.4295 | 0.4825 | 0.3523 |
| HbA1c Q1 residual RMS, percentage points (H01/H02/H03) | 0.4885 | 0.3480 | 0.4036 | 0.3006 |
| TC marginal sample SD, mg/dL (L01/L02/L03) | 42.847 | 35.799 | 43.678 | 35.206 |
| HDL marginal sample SD, mg/dL (L01/L02/L03) | 20.176 | 14.484 | 14.437 | 14.624 |

H02's HbA1c spread is closer to the reference than H03's, despite H03's closer Q3 coefficient. All three underrepresent HbA1c marginal and Q1 residual variation. L02 gives a TC SD close to the reference, while all three give lower HDL SDs and much lower lipid residual correlation. Thus the task that a virtual table might support matters: closeness for one coefficient or one marginal SD does not extend to residual variation, joint dependence, power calculations or interval calibration. The batch supplies no reference for the added lipid conditional-RMS diagnostics, so their target accuracy cannot be assessed. No missing reference is filled by analogy to marginal SD.

## What the source uses explain, and what they cannot establish

The three HbA1c constructions transfer the same adjusted age coefficient and use overlapping Finnish and Kerman information. H01/H02 use a marginal correlation/SD-derived glucose slope through an explicit conditional bridge and then a BMI decomposition. H03 instead solves a joint moment system using the marginal correlation and assumed reference-age dispersion. Their distributional and residual choices differ. These documents explain what each law contains and why different outputs are possible. The observed contrasts do not isolate the causal benefit of any one source, retrieval action, distribution family, marginal-to-conditional bridge or review step. Several settings change together, and there is no controlled intervention on those components.

All three lipid laws draw on the same rural Ashanti rank relationships through a Gaussian-copula assumption and a pooled-to-within-sex transfer. L01/L03 anchor lipid arithmetic moments to Agongo and use Greiner sex ratios; L02 instead combines Greiner geometric levels with Agongo CVs. Their BMI margins and age dependence also differ. L02's different TC spread is consistent with those explicitly different margin choices, but attributing the better SD proximity or worse slope proximity to a single choice would be unwarranted. The common low residual correlation is evidence of a shared limitation among these three completed laws in this exposed comparison; it does not identify a missing biological mechanism or prove that the common source relationship is intrinsically wrong.

The supported contribution is a concrete translation from incomplete, nonmatching literature summaries into full, finite-moment virtual cohorts whose analytical consequences can be inspected and compared. Preserving the distinctions between arithmetic and geometric summaries, marginal and conditional effects, rank and Pearson dependence, and individual dispersion and estimation uncertainty made the discrepancies interpretable. The data demonstrate some qualitative agreement alongside clear quantitative limitations. This is a contribution to transparent scenario construction and its assessment, not evidence that literature summaries uniquely identify the target joint distribution.

The controller reports 132 unavailable source checks across the six initial candidates. The reviewed declarations preserve unknown weighting and unsupported or incompletely reported operators instead of treating assumptions as source facts. These checks are not 132 passed comparisons, and their unavailability is not itself 132 generator failures. Since all six numerical laws were retained, this batch contains no before/after demonstration that source feedback improved final data. Static source review and implementation assurance are valuable, but they are distinct from demonstrated numerical benefit of a feedback loop. Optional retrieval also lacks a controlled benefit comparison.

## Scoped decision

**SIMPLIFY the claimed and intended use to task-specific, assumption-dependent scenario cohorts.** Retain this completed batch for pipeline prototyping, checking how declared laws produce the requested statistics, and documenting where transferred evidence fails to reproduce joint target features. Do not present the tables as interchangeable with measured target cohorts, as calibrated inputs for target effect estimation or power/uncertainty claims, or as proof of a generally effective feedback-improvement method. No construction is selected as a universal winner.

This decision closes interpretation of the present fixed batch; it requests no parameter change, replacement seed, new fit or additional experiment. Any later claim of empirical substitution or general improvement would require evidence beyond this exposed two-request development batch. Its current contribution stands on the final tables' transparent, partial usefulness and visible failures, with the reference limitations and unavailable comparisons preserved.
